UPXI · Insider Trading
Upexi, Inc. Common Stock
Every open-market purchase and sale reported by UPXI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-13 | Lawrence Dugan | Director | A | +104,000 | +$5.20K |
| 2026-11-13 | Thomas Charles Williams | Director | A | +100,000 | — |
| 2026-07-20 | Gene Salkind | Director | A | +100,000 | — |
| 2026-07-20 | Brian Benjamin Rudick | Chief Strategy Officer | A | +400,000 | — |
| 2026-07-20 | Andrew James Norstrud | Chief Financial Officer | A | +400,000 | — |
| 2026-07-20 | Lawrence Dugan | Director | A | +100,000 | — |
| 2026-07-20 | Allan Marshall | Chief Executive Officer | A | +2,000,000 | — |
| 2025-12-23 | Allan Marshall | Chief Executive Officer | Buy | +50,000 | +$90.00K |
| 2025-12-17 | Allan Marshall | Chief Executive Officer | MIXED | +1,750,000 | +$310.50K |
| 2025-11-21 | Gene Salkind | Director | Buy | +50,000 | +$127.50K |
| 2025-11-21 | Andrew James Norstrud | Chief Financial Officer | A | +240,000 | — |
| 2025-11-18 | Gene Salkind | Director | Buy | +200,000 | +$546.00K |
| 2025-07-30 | Gene Salkind | Director | MIXED | +220,243 | +$100.00K |
| 2025-07-24 | Andrew James Norstrud | Chief Financial Officer | A | +250,000 | — |
| 2025-07-24 | Brian Benjamin Rudick | CSO | A | +400,000 | — |
| 2025-07-24 | Thomas Charles Williams | Director | A | +100,000 | — |
| 2025-07-24 | Allan Marshall | Chief Executive Officer | MIXED | +1,361,943 | +$800.00K |
| 2025-07-24 | Lawrence Dugan | Director | MIXED | +116,000 | +$97.77K |
| 2025-04-25 | Andrew James Norstrud | Chief Financial Officer | MIXED | +143,860 | +$100.00K |
| 2025-04-25 | Lawrence Dugan | Director | A | +25,000 deriv. | — |
| 2025-04-25 | Gene Salkind | Director | Buy | +241,229 | +$550.00K |
| 2025-04-25 | Allan Marshall | Chief Executive Officer | MIXED | +732,895 | +$1.50M |
| 2025-04-25 | Thomas Charles Williams | Director | A | +25,000 deriv. | — |
| 2024-03-18 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +77,773 | +$44.74K |
| 2024-03-06 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +103,013 | +$72.11K |
| 2023-12-20 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +12,916 | +$12.34K |
| 2023-12-07 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +90,001 | +$84.95K |
| 2023-12-06 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +53,474 | +$40.65K |
| 2023-11-29 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +375,000 deriv. | — |
| 2023-07-07 | Allan Marshall | Chief Executive Officer | Buy | +79,945 | +$188.78K |
| 2023-05-23 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +22,776 | +$77.74K |
| 2023-03-20 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +13,001 | +$57.31K |
| 2023-01-11 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +17,303 | +$63.91K |
| 2022-12-13 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +12,000 | +$49.32K |
| 2022-12-05 | Allan Marshall | CHIEF EXECUTIVE OFFICER | Buy | +18,475 | +$73.16K |
| 2022-11-17 | Thomas Charles Williams | Director | A | +50,000 deriv. | — |
| 2022-11-17 | Lawrence Dugan | Director | A | +50,000 deriv. | — |
| 2022-11-17 | Gene Salkind | Director | A | +50,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Allan Marshall | Chief Executive Officer | 6,046,261 | $3.88M |
| Brian Benjamin Rudick | Chief Strategy Officer | 1,238,597 | $794.68K |
| Andrew James Norstrud | Chief Financial Officer | 1,049,138 | $673.13K |
| Gene Salkind | Director | 537,500 | $344.86K |
| Thomas Charles Williams | Director | 200,000 | $128.32K |
| Lawrence Dugan | Director | 120,389 | $77.24K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UPXI quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.